Okupe Oluyemi's Form 4/A amendment
AmendedHims & Hers Health, Inc. (HIMS) · filed May 29, 2025
- Accession no.
- 0001773751-25-000172
- Filed
- May 29, 2025
- Trade date
- May 15, 2025
- Filing delay
- 14 days
- Rule 10b5-1 plan
- Checked
- Original filed
- May 19, 2025
This filing lists 2 derivative transactions. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $697.4K. It was filed 14 days after the trade.
This amendment restates part of 0001773751-25-000166 (filed May 19, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −548 | $0.00 | $0 | 63,784 | Direct | |
| May 15, 2025 | Class A Common Stock | MOption exerciseDisposed | −5,889 | $0.00 | $0 | 393,407 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001773751-25-000166 (filed May 19, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +5,889 | $11.53 | +$67,900.17 | 124,849 | Direct | |
| May 15, 2025 | Class A Common Stock | MOption exerciseAcquired | +548 | $5.01 | +$2,745.48 | 125,397 | Direct | |
| May 15, 2025 | Class A Common Stock | SSaleDisposed | −11,581 | $60.22F2 | −$697,407.82 | 113,816 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.82 - $60.72. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person.
- F2
The number has been updated to reflect the correct number of options exercised .
- F3
The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.
- F4
25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date.